GlassScriptPhysician profile
Paolo Angelini
NPI 1114947645
$7,197.35
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,234 · 2020: $658 · 2021: $1,731 · 2022: $2,094 · 2023: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $413.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,411.44 | 2019-2022 | |
| Amgen INC. | $824.92 | 2019-2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $659.18 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $421.99 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $414.31 | 2019-2022 | |
| Boston Scientific Corporation | $406.13 | 2020-2023 | Watchman Access System |
| Actelion Pharmaceuticals US, INC. | $338.61 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $323.68 | 2019-2022 | |
| Abbott Laboratories | $264.04 | 2021-2023 | Cardiomems |
| Pfizer INC. | $227.05 | 2019-2021 | |
| Novo Nordisk INC | $213.80 | 2022 | |
| Esperion Therapeutics, INC. | $209.72 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $208.80 | 2019 | |
| Impulse Dynamics (USA) INC. | $194.13 | 2022-2023 | Optimizer |
| Astellas Pharma US INC | $137.44 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akcea Therapeutics, INC. | $115.78 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.48 | 2019-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $107.85 | 2021-2022 | |
| Amarin Pharma, INC. | $85.86 | 2022 | |
| Endologix LLC | $68.94 | 2021 | |
| Heartflow, INC. | $67.65 | 2019-2022 | |
| Vifor Pharma, INC. | $65.09 | 2021 | |
| Irhythm Technologies, INC. | $48.73 | 2020-2023 | Zio Xt Patch |
| Bayer Healthcare Pharmaceuticals INC. | $41.42 | 2022 | |
| Inari Medical, INC. | $39.16 | 2021-2022 | |
| Chiesi USA, INC. | $28.82 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $26.01 | 2019-2021 | |
| Avinger INC. | $20.41 | 2021 | |
| Arbor Pharmaceuticals, INC. | $18.12 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $17.67 | 2023 | Arcalyst |
| Medtronic, INC. | $11.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paolo Angelini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.